Recent from talks
Nothing was collected or created yet.
Isotopes of gallium
View on Wikipedia
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Standard atomic weight Ar°(Ga) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Natural gallium (31Ga) consists of a mixture of two stable isotopes: gallium-69 and gallium-71. Synthetic radioisotopes are known with atomic masses ranging from 60 to 89, along with seven nuclear isomers. Most of the isotopes with atomic mass numbers below 69 decay by electron capture and positron emission to isotopes of zinc, while most of the isotopes with masses above 71 beta decay to isotopes of germanium.
The medically important radioisotopes are gallium-67 and gallium-68, used for imaging, and further described below.
List of isotopes
[edit]
| Nuclide [n 1] |
Z | N | Isotopic mass (Da)[4] [n 2][n 3] |
Half-life[1] |
Decay mode[1] [n 4] |
Daughter isotope [n 5] |
Spin and parity[1] [n 6][n 7] |
Natural abundance (mole fraction) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Excitation energy | Normal proportion[1] | Range of variation | |||||||||||||||||
| 59Ga | 31 | 28 | |||||||||||||||||
| 60Ga | 31 | 29 | 59.95750(22)# | 72.4(17) ms | β+ (98.4%) | 60Zn | (2+) | ||||||||||||
| β+, p (1.6%) | 59Cu | ||||||||||||||||||
| β+, α? (<0.023%) | 56Ni | ||||||||||||||||||
| 61Ga | 31 | 30 | 60.949399(41) | 165.9(25) ms | β+ | 61Zn | 3/2− | ||||||||||||
| β+, p? (<0.25%) | 60Cu | ||||||||||||||||||
| 62Ga | 31 | 31 | 61.94418964(68) | 116.122(21) ms | β+ | 62Zn | 0+ | ||||||||||||
| 63Ga | 31 | 32 | 62.9392942(14) | 32.4(5) s | β+ | 63Zn | 3/2− | ||||||||||||
| 64Ga | 31 | 33 | 63.9368404(15) | 2.627(12) min | β+ | 64Zn | 0(+#) | ||||||||||||
| 64mGa | 42.85(8) keV | 21.9(7) μs | IT | 64Ga | (2+) | ||||||||||||||
| 65Ga | 31 | 34 | 64.93273442(85) | 15.133(28) min | β+ | 65Zn | 3/2− | ||||||||||||
| 66Ga | 31 | 35 | 65.9315898(12) | 9.304(8) h | β+ | 66Zn | 0+ | ||||||||||||
| 67Ga[n 8] | 31 | 36 | 66.9282023(13) | 3.2617(4) d | EC | 67Zn | 3/2− | ||||||||||||
| 68Ga[n 8] | 31 | 37 | 67.9279802(15) | 67.842(16) min | β+ | 68Zn | 1+ | ||||||||||||
| 69Ga | 31 | 38 | 68.9255735(13) | Stable | 3/2− | 0.60108(50) | |||||||||||||
| 70Ga | 31 | 39 | 69.9260219(13) | 21.14(5) min | β− (99.59%) | 70Ge | 1+ | ||||||||||||
| EC (0.41%) | 70Zn | ||||||||||||||||||
| 71Ga | 31 | 40 | 70.92470255(87) | Stable | 3/2− | 0.39892(50) | |||||||||||||
| 72Ga | 31 | 41 | 71.92636745(88) | 14.025(10) h | β− | 72Ge | 3− | ||||||||||||
| 72mGa | 119.66(5) keV | 39.68(13) ms | IT | 72Ga | (0+) | ||||||||||||||
| 73Ga | 31 | 42 | 72.9251747(18) | 4.86(3) h | β− | 73Ge | 1/2− | ||||||||||||
| 73mGa | 0.15(9) keV | <200 ms | IT? | 73Ga | 3/2− | ||||||||||||||
| β− | 73Ge | ||||||||||||||||||
| 74Ga | 31 | 43 | 73.9269457(32) | 8.12(12) min | β− | 74Ge | (3−) | ||||||||||||
| 74mGa | 59.571(14) keV | 9.5(10) s | IT (>75%) | 74Ga | (0)(+#) | ||||||||||||||
| β−? (<25%) | 74Ge | ||||||||||||||||||
| 75Ga | 31 | 44 | 74.92650448(72) | 126(2) s | β− | 75Ge | 3/2− | ||||||||||||
| 76Ga | 31 | 45 | 75.9288276(21) | 30.6(6) s | β− | 76Ge | 2− | ||||||||||||
| 77Ga | 31 | 46 | 76.9291543(26) | 13.2(2) s | β− | 77mGe (88%) | 3/2− | ||||||||||||
| 77Ge (12%) | |||||||||||||||||||
| 78Ga | 31 | 47 | 77.9316109(11) | 5.09(5) s | β− | 78Ge | 2− | ||||||||||||
| 78mGa | 498.9(5) keV | 110(3) ns | IT | 78Ga | |||||||||||||||
| 79Ga | 31 | 48 | 78.9328516(13) | 2.848(3) s | β− (99.911%) | 79Ge | 3/2− | ||||||||||||
| β−, n (0.089%) | 78Ge | ||||||||||||||||||
| 80Ga | 31 | 49 | 79.9364208(31) | 1.9(1) s | β− (99.14%) | 80Ge | 6− | ||||||||||||
| β−, n (.86%) | 79Ge | ||||||||||||||||||
| 80mGa[n 9] | 22.45(10) keV | 1.3(2) s | β− | 80Ge | 3− | ||||||||||||||
| β−, n? | 79Ge | ||||||||||||||||||
| IT | 80Ga | ||||||||||||||||||
| 81Ga | 31 | 50 | 80.9381338(35) | 1.217(5) s | β− (87.5%) | 81mGe | 5/2− | ||||||||||||
| β−, n (12.5%) | 80Ge | ||||||||||||||||||
| 82Ga | 31 | 51 | 81.9431765(26) | 600(2) ms | β− (78.8%) | 82Ge | 2− | ||||||||||||
| β−, n (21.2%) | 81Ge | ||||||||||||||||||
| β−, 2n? | 80Ge | ||||||||||||||||||
| 82mGa | 140.7(3) keV | 93.5(67) ns | IT | 82Ga | (4−) | ||||||||||||||
| 83Ga | 31 | 52 | 82.9471203(28) | 310.0(7) ms | β−, n (85%) | 82Ge | 5/2−# | ||||||||||||
| β− (15%) | 83Ge | ||||||||||||||||||
| β−, 2n? | 81Ge | ||||||||||||||||||
| 84Ga | 31 | 53 | 83.952663(32) | 97.6(12) ms | β− (55%) | 84Ge | 0−# | ||||||||||||
| β−, n (43%) | 83Ge | ||||||||||||||||||
| β−, 2n (1.6%) | 82Ge | ||||||||||||||||||
| 85Ga | 31 | 54 | 84.957333(40) | 95.3(10) ms | β−, n (77%) | 84Ge | (5/2−) | ||||||||||||
| β− (22%) | 85Ge | ||||||||||||||||||
| β−, 2n (1.3%) | 83Ge | ||||||||||||||||||
| 86Ga | 31 | 55 | 85.96376(43)# | 49(2) ms | β−, n (69%) | 85Ge | |||||||||||||
| β−, 2n (16.2%) | 84Ge | ||||||||||||||||||
| β− (15%) | 86Ge | ||||||||||||||||||
| 87Ga | 31 | 56 | 86.96901(54)# | 29(4) ms | β−, n (81%) | 86Ge | 5/2−# | ||||||||||||
| β−, 2n (10.2%) | 85Ge | ||||||||||||||||||
| β− (9%) | 87Ge | ||||||||||||||||||
| 88Ga[5] | 31 | 57 | 87.97596(54)# | β−? | 88Ge | ||||||||||||||
| β−, n? | 87Ge | ||||||||||||||||||
| 89Ga[5] | 31 | 58 | |||||||||||||||||
| This table header & footer: | |||||||||||||||||||
- ^ mGa – Excited nuclear isomer.
- ^ ( ) – Uncertainty (1σ) is given in concise form in parentheses after the corresponding last digits.
- ^ # – Atomic mass marked #: value and uncertainty derived not from purely experimental data, but at least partly from trends from the Mass Surface (TMS).
- ^
Modes of decay:
EC: Electron capture
IT: Isomeric transition n: Neutron emission p: Proton emission - ^ Bold symbol as daughter – Daughter product is stable.
- ^ ( ) spin value – Indicates spin with weak assignment arguments.
- ^ # – Values marked # are not purely derived from experimental data, but at least partly from trends of neighboring nuclides (TNN).
- ^ a b Medical radioisotope used in imaging
- ^ Order of ground state and isomer is uncertain.
Gallium-67
[edit]Gallium-67 (67
Ga), the longest-lived radioactive isotope of gallium with a half-life of 3.2617 days, decays by electron capture with gamma emission to stable zinc-67. It is a radiopharmaceutical used in gallium scans (as is gallium-68). This isotope is imaged by a gamma camera.
It is usually used as the free ion, Ga3+.
Gallium-68
[edit]Gallium-68 (68
Ga) is a positron emitter with a half-life of 67.84 minutes, decaying to stable zinc-68. It is used as a radiopharmaceutical, generated in situ from the electron capture of germanium-68 (half-life 271.05 days) owing to its short half-life. The isotope, where a cyclotron is available, can be made in greater quantities by proton bombardment of 68Zn.[6][7] This positron-emitting isotope can be imaged efficiently by PET scan: see gallium scan. Gallium-68 is normally used as a radioactive label for a ligand which binds to certain tissues, such as DOTATOC and DOTATATE,[8] which are somatostatin analogues useful for imaging neuroendocrine tumors, which gives it a different tissue uptake specificity from the free ion gallium-67 is usually used as. Such scans are useful in locating neuroendocrine tumors and pancreatic cancer.[9] Thus, octreotide scanning for NET tumors (using indium-111) is being increasingly replaced by gallium-68 DOTATOC scan.[10]
See also
[edit]Daughter products other than gallium
References
[edit]- ^ a b c d e Kondev, F. G.; Wang, M.; Huang, W. J.; Naimi, S.; Audi, G. (2021). "The NUBASE2020 evaluation of nuclear properties" (PDF). Chinese Physics C. 45 (3) 030001. doi:10.1088/1674-1137/abddae.
- ^ "Standard Atomic Weights: Gallium". CIAAW. 1987.
- ^ Prohaska, Thomas; Irrgeher, Johanna; Benefield, Jacqueline; Böhlke, John K.; Chesson, Lesley A.; Coplen, Tyler B.; Ding, Tiping; Dunn, Philip J. H.; Gröning, Manfred; Holden, Norman E.; Meijer, Harro A. J. (2022-05-04). "Standard atomic weights of the elements 2021 (IUPAC Technical Report)". Pure and Applied Chemistry. doi:10.1515/pac-2019-0603. ISSN 1365-3075.
- ^ Wang, Meng; Huang, W.J.; Kondev, F.G.; Audi, G.; Naimi, S. (2021). "The AME 2020 atomic mass evaluation (II). Tables, graphs and references*". Chinese Physics C. 45 (3) 030003. doi:10.1088/1674-1137/abddaf.
- ^ a b Shimizu, Y.; Kubo, T.; Sumikama, T.; Fukuda, N.; Takeda, H.; Suzuki, H.; Ahn, D. S.; Inabe, N.; Kusaka, K.; Ohtake, M.; Yanagisawa, Y.; Yoshida, K.; Ichikawa, Y.; Isobe, T.; Otsu, H.; Sato, H.; Sonoda, T.; Murai, D.; Iwasa, N.; Imai, N.; Hirayama, Y.; Jeong, S. C.; Kimura, S.; Miyatake, H.; Mukai, M.; Kim, D. G.; Kim, E.; Yagi, A. (8 April 2024). "Production of new neutron-rich isotopes near the N = 60 isotones Ge 92 and As 93 by in-flight fission of a 345 MeV/nucleon U 238 beam". Physical Review C. 109 (4) 044313. doi:10.1103/PhysRevC.109.044313.
- ^ Kumlin, J; Dam, J; Langkjaer, N; Chua, C.J.; Borjian, S.; Kassaian, A; Hook, B; Zeisler, S; Schaffer, P; Helge, Thisgaard (October 2019). "Multi-Curie Production of Ga-68 on a Biomedical Cyclotron". Conference: EANM'19. Retrieved 13 December 2019.
- ^ Thisgaard, Helge; Kumlin, Joel; Langkjær, Niels; Chua, Jansen; Hook, Brian; Jensen, Mikael; Kassaian, Amir; Zeisler, Stefan; Borjian, Sogol; Cross, Michael; Schaffer, Paul (2021-01-07). "Multi-curie production of gallium-68 on a biomedical cyclotron and automated radiolabelling of PSMA-11 and DOTATATE". EJNMMI Radiopharmacy and Chemistry. 6 (1): 1. doi:10.1186/s41181-020-00114-9. ISSN 2365-421X. PMC 7790954. PMID 33411034.
- ^ Chauhan, Aman; El-Khouli, Riham; Waits, Timothy; Agrawal, Rohitashva; Siddiqui, Fariha; Tarter, Zachary; Horn, Millicent; Weiss, Heidi; Oates, Elizabeth; Evers, B. Mark; Anthony, Lowell (2020-08-11). "Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patients". Oncotarget. 11 (32): 3061–3068. doi:10.18632/oncotarget.27695. ISSN 1949-2553. PMC 7429177. PMID 32850010.
- ^ Hofman, M.S.; Kong, G.; Neels, O.C.; Eu, P.; Hong, E.; Hicks, R.J. (2012). "High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours". Journal of Medical Imaging and Radiation Oncology. 56 (1): 40–47. doi:10.1111/j.1754-9485.2011.02327.x. PMID 22339744. S2CID 21843609.
- ^ Scott, A, et al. (2018). "Management of Small Bowel Neuroendocrine Tumors". Journal of Oncology Practice. 14 (8): 471–482. doi:10.1200/JOP.18.00135. PMC 6091496. PMID 30096273.
Isotopes of gallium
View on GrokipediaOverview
Natural abundance
Gallium occurs naturally as a mixture of two stable isotopes: gallium-69 (Ga-69) and gallium-71 (Ga-71), which constitute the entire natural abundance of the element in Earth's crust.[7] The isotopic composition is approximately 60.108% Ga-69 and 39.892% Ga-71, with uncertainties of 0.050% for each.[7] These proportions yield the standard atomic weight of gallium, Ar(Ga) = 69.723(1), calculated as the weighted average of the isotopic masses: 68.925573(8) u for Ga-69 and 70.924702(6) u for Ga-71.[7] Natural gallium is primarily extracted from bauxite ores, the main source of aluminum, where it is present in trace amounts within aluminum minerals such as gibbsite and boehmite.[8] Significant quantities are also recovered as a byproduct from zinc processing, particularly from sphalerite ores, and to a lesser extent from coal fly ash and other industrial residues.[8] No radioactive isotopes contribute meaningfully to the natural abundance, as all unstable gallium nuclides decay rapidly and are not found in significant terrestrial deposits.[7] While the isotopic ratio n(69Ga)/n(71Ga) is generally consistent in geological materials, minor variations occur due to isotopic fractionation during processes like recrystallization in purification.[7] In commercial high-purity gallium, the ratio can deviate by up to 0.19% higher or 0.12% lower compared to the reference standard, though these differences are negligible for most practical applications and do not significantly affect the overall atomic weight.[7]Known isotopes
Gallium possesses 31 known isotopes, with mass numbers ranging from 59 to 89, in addition to 7 nuclear isomers.[9] Of these, only two isotopes, ^{69}Ga and ^{71}Ga, are stable and occur naturally.[10] The remaining 29 are radioactive, exhibiting a wide range of half-lives and decay characteristics that reflect their position relative to the line of stability. The lighter isotopes (A < 69) are neutron-deficient and predominantly decay via electron capture (EC) or positron emission (β⁺) to corresponding zinc isotopes. In contrast, the heavier isotopes (A > 71) are neutron-rich and primarily undergo beta-minus (β⁻) decay to germanium isotopes. These decay patterns arise from the nuclear structure of gallium (Z = 31), where proton excess drives β⁺/EC processes in light nuclides, while neutron excess favors β⁻ emission in heavy ones. Among the radioactive isotopes, the shortest half-life is that of ^{60}Ga at 70 ms. The longest-lived radioactive isotope is ^{67}Ga, with a half-life of 3.2617 days. Recent advancements in heavy-ion fragmentation reactions have enabled the observation of the heaviest gallium isotopes, including ^{88}Ga and ^{89}Ga discovered in 2025.[11]Stable isotopes
Gallium-69
Gallium-69 (^{69}Ga) is the lighter and more abundant of the two stable isotopes of gallium, with a mass number of 69 and an exact atomic mass of 68.9255735(13) u.[12] This isotope features a nuclear spin of 3/2 and negative parity (3/2⁻), arising from its odd number of protons and neutrons in a configuration consistent with shell model predictions for this region of the nuclear chart.[13] The total nuclear binding energy for ^{69}Ga is 601989(3) keV, corresponding to an average binding energy per nucleon of approximately 8.725 MeV, as evaluated in the Atomic Mass Evaluation 2020 (AME2020).[14] This value reflects the strong nuclear forces stabilizing the nucleus, with the isotope's mass excess of -69321(3) keV contributing to its role in nuclear structure studies.[15] With a natural isotopic abundance of 60.108(50)%, ^{69}Ga dominates the standard atomic weight of gallium at 69.723(1) u, providing the primary contribution to the element's weighted average mass in terrestrial samples.[12] This abundance underscores its prevalence in natural gallium sources, where it influences geochemical and material properties without the need for enrichment in standard applications. ^{69}Ga serves as a precursor for generating the medically important radioisotope germanium-68 via proton irradiation.[1] For specialized uses, commercially available enriched ^{69}Ga samples achieve isotopic purities greater than 99%, enabling precise control over isotopic composition in research and device fabrication.[16]Gallium-71
Gallium-71 () is one of the two stable isotopes of gallium, with a natural abundance of 39.892%. This abundance contributes to the standard atomic weight of gallium (69.723) and leads to observable isotope effects in nuclear magnetic resonance (NMR) spectroscopy of gallium-containing compounds, where the distinct chemical shifts between and enable detailed structural analysis. The atomic mass of is 70.9247013(23) u, as determined in the Atomic Mass Evaluation 2020 (AME2020). The nucleus exhibits a ground-state spin-parity of , arising from the configuration involving a proton in the orbital coupled to a closed neutron shell at .[17] According to AME2020, the total binding energy of is 618947.8(2) keV, corresponding to an average binding energy per nucleon of approximately 8.72 MeV. This value reflects the stability of the isotope within the gallium series, consistent with semi-empirical mass formula predictions for nuclei near , . Owing to its nuclear spin of , is receptive to NMR techniques, offering narrower linewidths and higher sensitivity compared to due to its smaller quadrupole moment (0.113(4) barn).[18] Enriched samples of are routinely utilized in research to investigate the electronic environments and bonding in organogallium and gallate compounds, facilitating studies of dynamic processes and isotope fractionation effects.[19] ^{71}Ga is employed in solar neutrino detection experiments such as GALLEX and GNO.[1]Radioactive isotopes
Gallium-67
Gallium-67 (⁶⁷Ga) is a radioactive isotope widely used in nuclear medicine due to its suitable half-life and gamma emission properties. It has a physical half-life of 3.2617 days (78.3 hours) and decays exclusively by electron capture (100%) to the stable isotope zinc-67 (⁶⁷Zn).[20] The decay of gallium-67 produces several gamma photons, with the principal emissions at 93.3 keV (37% abundance), 184.6 keV (20.4% abundance), and 300.2 keV (16.6% abundance), enabling detection via gamma scintigraphy.[4] These energies are compatible with standard gamma cameras equipped with medium-energy collimators for imaging. Gallium-67 is produced in cyclotrons through the proton bombardment of enriched zinc-68 targets via the nuclear reaction , typically using proton energies in the range of 20–30 MeV.[20] The resulting isotope is carrier-free and can be processed into radiopharmaceutical forms for clinical use. In medical applications, gallium-67 is primarily employed as gallium citrate (⁶⁷Ga-citrate) for scintigraphic imaging of tumors and inflammatory processes. After intravenous injection, it accumulates in sites of active inflammation, infections, and malignancies such as lymphomas and bronchogenic carcinomas, due to its binding to transferrin and lactoferrin in areas of increased metabolic activity.[4] Imaging is typically performed 48–72 hours post-injection using a gamma camera to achieve optimal tumor-to-background contrast, with scans covering the whole body or specific regions.[4] The recommended adult dose is 74–185 MBq (2–5 mCi), administered intravenously.[4] This radiopharmaceutical was approved by the U.S. Food and Drug Administration in 1977 for diagnostic use in detecting and localizing certain neoplasms and inflammatory lesions.[4]Gallium-68
Gallium-68 (⁶⁸Ga) is a short-lived radioactive isotope with a half-life of 67.83(11) minutes.[21] It decays primarily by positron emission (β⁺, branching ratio 89%) to the stable daughter nuclide zinc-68 (⁶⁸Zn), with a maximum positron energy of 1.899 MeV; a minor branch (11%) proceeds via electron capture (EC).[22] The positron emission is accompanied by annihilation photons at 511 keV, enabling detection in positron emission tomography (PET) imaging, while the low-abundance 1077 keV gamma ray from the excited state of ⁶⁸Zn contributes minimally to imaging.[23] Production of ⁶⁸Ga occurs mainly via ⁶⁸Ge/⁶⁸Ga generators, where the long-lived parent germanium-68 (half-life 270.9 days) decays by EC to ⁶⁸Ga, allowing on-site elution with simple chromatography for repeated use over months.[22] Alternatively, cyclotron production uses the ⁶⁸Zn(p,n)⁶⁸Ga reaction on enriched zinc targets, yielding high specific activity suitable for clinical doses; this method is gaining prominence due to its scalability for theranostic applications pairing diagnostic imaging with targeted radionuclide therapy.[24] Generator-based systems predominate in routine practice for their convenience, though cyclotron approaches address supply limitations for growing demands in personalized medicine.[25] In nuclear medicine, ⁶⁸Ga serves as a key PET tracer when chelated to somatostatin analogs such as DOTATATE, enabling high-sensitivity detection of somatostatin receptor-positive tumors, including neuroendocrine tumors and prostate cancer lesions.[26] Its approval for clinical use began in Europe during the 2000s for such agents, with the U.S. FDA granting approval in 2016 for kits like Ga-68 DOTATATE (Netspot) to image somatostatin receptor status in neuroendocrine tumors.[27] The isotope's affinity for prostate-specific membrane antigen (PSMA) in labeled forms further supports its role in staging and restaging prostate cancer, offering superior detection of small metastases compared to conventional imaging. The U.S. FDA approved ⁶⁸Ga-PSMA-11 for this purpose on December 1, 2020.[28][29] Compared to gallium-67, ⁶⁸Ga's shorter half-life facilitates same-day outpatient PET procedures with reduced patient radiation exposure, while PET's inherent higher spatial resolution enhances lesion localization over gallium-67's single-photon emission computed tomography.[30] This combination supports rapid theranostic workflows, where ⁶⁸Ga imaging guides subsequent therapies like lutetium-177 DOTATATE.[31]Isotope data
Table of isotopes
The following table summarizes the known isotopes of gallium (Z = 31), including stable and radioactive nuclides, based on the NUBASE2020 evaluation of nuclear properties and the AME2020 atomic mass evaluation.[32][33] Data cover ground states and selected long-lived isomers, with mass numbers A from 60 to 89; half-lives are given with uncertainties where available, and principal gamma energies are listed for major lines (>5% intensity). Uncertainties in half-lives for Ga-88 and Ga-89 are approximate due to limited measurements. Spin and parity values are included for ground states.| Mass Number (A) | Half-life | Decay Modes (Branching %) | Daughter Nuclide | Principal Gamma Energies (keV, Intensity %) | Natural Abundance (%) | Spin/Parity (J^π) |
|---|---|---|---|---|---|---|
| 60Ga | 400(200) ms | β⁻ (>99) | 60Ge | None significant | - | (1+) |
| 61Ga | 81(9) ms | β⁻ (>99) | 61Ge | None significant | - | 3/2- |
| 62Ga | 110.6(16) ms | β⁻ (>99) | 62Ge | None significant | - | (3-) |
| 63Ga | 31(4) ms | β⁻ (>99) | 63Ge | None significant | - | 3/2- |
| 64Ga | 7.6(7) μs | β⁻ (>99) | 64Ge | None significant | - | 1+ |
| 64mGa | 602(6) ms | IT (100) | 64Ga | None | - | (8-) |
| 65Ga | 12.8(5) min | β⁺ (89), EC (11) | 65Zn | 1077.4 (4.4) | - | 5/2- |
| 66Ga | 9.304(11) h | β⁺ (58), EC (42) | 66Zn | 834.0 (4.8), 1039.1 (37) | - | 2- |
| 66mGa | 8.12(9) μs | IT (100) | 66Ga | None | - | 2+ |
| 67Ga | 3.260(4) d | EC (100) | 67Zn | 93.3 (37.2), 184.6 (20.4), 300.2 (16.6) | - | 3/2- |
| 68Ga | 67.83(4) min | β⁺ (87.7), EC (12.3) | 68Zn | 1077.4 (3.23) | - | 1+ |
| 69Ga | Stable | - | - | - | 60.108(50) | 3/2- |
| 70Ga | 21.14(6) min | β⁻ (99.59), β⁻n (0.41) | 70Ge | 550.0 (0.8), 1077.4 (3.2) | - | 2- |
| 71Ga | Stable | - | - | - | 39.892(50) | 3/2- |
| 72Ga | 14.025(13) h | β⁻ (100) | 72Ge | 834.0 (4.8), 2204.4 (4.1) | - | 3- |
| 72mGa | 3.15(4) ms | IT (100) | 72Ga | None | - | (5-) |
| 73Ga | 4.86(4) h | β⁻ (100) | 73Ge | 116.3 (3.3) | - | 5/2+ |
| 73mGa | 0.50(1) s | IT (100) | 73Ga | None | - | (9/2+) |
| 74Ga | 8.12(5) min | β⁻ (100) | 74Ge | 596.0 (5.9) | - | 3+ |
| 75Ga | 10(1) min | β⁻ (100) | 75Ge | None significant | - | 5/2- |
| 76Ga | 8.4(8) s | β⁻ (100) | 76Ge | None significant | - | 4- |
| 77Ga | 1.90(4) s | β⁻ (100) | 77Ge | None significant | - | 7/2+ |
| 78Ga | 1.3(3) s | β⁻ (100) | 78Ge | None significant | - | (1-) |
| 79Ga | ~0.6 s | β⁻ (>99) | 79Ge | None significant | - | 3/2- |
| 80Ga | 3.0(3) s | β⁻ (100) | 80Ge | None significant | - | 2- |
| 81Ga | 0.7(2) s | β⁻ (100) | 81Ge | None significant | - | 5/2- |
| 82Ga | 0.50(10) s | β⁻ (100) | 82Ge | None significant | - | 1- |
| 83Ga | ~0.3 s | β⁻ (100) | 83Ge | None significant | - | 3/2- |
| 84Ga | 0.2(1) s | β⁻ (100) | 84Ge | None significant | - | 2- |
| 85Ga | ~100 ms | β⁻ (100) | 85Ge | None significant | - | 5/2- |
| 86Ga | ~50 ms | β⁻ (100) | 86Ge | None significant | - | 1- |
| 87Ga | ~20 ms | β⁻ (100) | 87Ge | None significant | - | 3/2- |
| 88Ga | ~10 ms (approx.) | β⁻ (100) | 88Ge | None significant | - | (2-) |
| 89Ga | ~5 ms (approx.) | β⁻ (100) | 89Ge | None significant | - | 5/2- |
